APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acinetobacter Infections Treatment

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.

Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.

Selected research

Industry Growth & Trends

Global Acinetobacter Infections Treatment Industry Growth and Trends Forecast to 2032

2 January 2026103 pages

Choose your research edition.

Industry ResearchAcinetobacter Infections Treatment Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Acinetobacter Infections Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Acinetobacter Infections Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acinetobacter Infections Treatment Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Acinetobacter Infections Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.

Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.

Read the full market overview

According to APO Research, the global Acinetobacter Infections Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

This report provides a structured, data-driven view of the global Acinetobacter Infections Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Acinetobacter Infections Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acinetobacter Infections Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acinetobacter Infections Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Acinetobacter Infections Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Acinetobacter Infections Treatment Market by Company

Entasis Therapeutics

Roche

Adenium Biotech

Vaxdyn

Hsiri Therapeutics

Aridis Pharmaceuticals

LegoChem Biosciences

Atterx Biotherapeutics

Achaogen

Peptilogics

Sealife PHARMA

Shionogi

Techulon

Tetraphase Pharmaceuticals

Acinetobacter Infections Treatment Segment by Type

Sulbactam

Carbapenems

Aminoglycosides

Polymyxins

Tetracyclines

Others

Acinetobacter Infections Treatment Segment by Pipeline

ETX2514

Nacubactam RG6080

Arenicin

VXD-001

Small Molecule Antibiotic

AR-401 mAB

LCB01-0371 (PO)

GN-4474

Antibacterial Antibody

Others

Acinetobacter Infections Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acinetobacter Infections Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acinetobacter Infections Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acinetobacter Infections Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Acinetobacter Infections Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Acinetobacter Infections Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Acinetobacter Infections Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Acinetobacter Infections Treatment Market Share by Region (2021-2026) Table 4. Global Acinetobacter Infections Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Acinetobacter Infections Treatment Market Share by Region (2027-2032) Table 6. Global Acinetobacter Infections Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Acinetobacter Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Acinetobacter Infections Treatment Market Size Share by Type (2021-2026) Table 9. Global Acinetobacter Infections Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Acinetobacter Infections Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Acinetobacter Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Acinetobacter Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Acinetobacter Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Acinetobacter Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Acinetobacter Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Acinetobacter Infections Treatment Market Size by Pipeline (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Acinetobacter Infections Treatment Market Size by Pipeline (2021-2026) & (US$ Million) Table 23. Global Acinetobacter Infections Treatment Market Size Share by Pipeline (2021-2026) Table 24. Global Acinetobacter Infections Treatment Market Size Forecasted by Pipeline (2027-2032) & (US$ Million) Table 25. Global Acinetobacter Infections Treatment Market Size Share Forecasted by Pipeline (2027-2032) Table 26. North America Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026) & (US$ Million) Table 27. North America Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2027-2032) & (US$ Million) Table 28. Europe Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026) & (US$ Million) Table 29. Europe Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2027-2032) & (US$ Million) Table 30. Asia-Pacific Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026) & (US$ Million) Table 31. Asia-Pacific Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2027-2032) & (US$ Million) Table 32. Latin America Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026) & (US$ Million) Table 33. Latin America Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2027-2032) & (US$ Million) Table 34. Middle East and Africa Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026) & (US$ Million) Table 35. Middle East and Africa Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2027-2032) & (US$ Million) Table 36. Acinetobacter Infections Treatment Industry Trends Table 37. Acinetobacter Infections Treatment Industry Drivers Table 38. Acinetobacter Infections Treatment Industry Opportunities and Challenges Table 39. Acinetobacter Infections Treatment Industry Restraints Table 40. Global Acinetobacter Infections Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Acinetobacter Infections Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Acinetobacter Infections Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Acinetobacter Infections Treatment Key Company Headquarters & Area Served Table 44. Global Acinetobacter Infections Treatment Company, Product Type & Application Table 45. Global Acinetobacter Infections Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Acinetobacter Infections Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Entasis Therapeutics Company Information Table 49. Entasis Therapeutics Business Overview Table 50. Entasis Therapeutics Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Entasis Therapeutics Acinetobacter Infections Treatment Product Portfolio Table 52. Entasis Therapeutics Recent Development Table 53. Roche Company Information Table 54. Roche Business Overview Table 55. Roche Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Roche Acinetobacter Infections Treatment Product Portfolio Table 57. Roche Recent Development Table 58. Adenium Biotech Company Information Table 59. Adenium Biotech Business Overview Table 60. Adenium Biotech Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Adenium Biotech Acinetobacter Infections Treatment Product Portfolio Table 62. Adenium Biotech Recent Development Table 63. Vaxdyn Company Information Table 64. Vaxdyn Business Overview Table 65. Vaxdyn Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Vaxdyn Acinetobacter Infections Treatment Product Portfolio Table 67. Vaxdyn Recent Development Table 68. Hsiri Therapeutics Company Information Table 69. Hsiri Therapeutics Business Overview Table 70. Hsiri Therapeutics Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Hsiri Therapeutics Acinetobacter Infections Treatment Product Portfolio Table 72. Hsiri Therapeutics Recent Development Table 73. Aridis Pharmaceuticals Company Information Table 74. Aridis Pharmaceuticals Business Overview Table 75. Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Portfolio Table 77. Aridis Pharmaceuticals Recent Development Table 78. LegoChem Biosciences Company Information Table 79. LegoChem Biosciences Business Overview Table 80. LegoChem Biosciences Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. LegoChem Biosciences Acinetobacter Infections Treatment Product Portfolio Table 82. LegoChem Biosciences Recent Development Table 83. Atterx Biotherapeutics Company Information Table 84. Atterx Biotherapeutics Business Overview Table 85. Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Atterx Biotherapeutics Acinetobacter Infections Treatment Product Portfolio Table 87. Atterx Biotherapeutics Recent Development Table 88. Achaogen Company Information Table 89. Achaogen Business Overview Table 90. Achaogen Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Achaogen Acinetobacter Infections Treatment Product Portfolio Table 92. Achaogen Recent Development Table 93. Peptilogics Company Information Table 94. Peptilogics Business Overview Table 95. Peptilogics Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Peptilogics Acinetobacter Infections Treatment Product Portfolio Table 97. Peptilogics Recent Development Table 98. Sealife PHARMA Company Information Table 99. Sealife PHARMA Business Overview Table 100. Sealife PHARMA Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sealife PHARMA Acinetobacter Infections Treatment Product Portfolio Table 102. Sealife PHARMA Recent Development Table 103. Shionogi Company Information Table 104. Shionogi Business Overview Table 105. Shionogi Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Shionogi Acinetobacter Infections Treatment Product Portfolio Table 107. Shionogi Recent Development Table 108. Techulon Company Information Table 109. Techulon Business Overview Table 110. Techulon Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Techulon Acinetobacter Infections Treatment Product Portfolio Table 112. Techulon Recent Development Table 113. Tetraphase Pharmaceuticals Company Information Table 114. Tetraphase Pharmaceuticals Business Overview Table 115. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Portfolio Table 117. Tetraphase Pharmaceuticals Recent Development Table 118. North America Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Acinetobacter Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Acinetobacter Infections Treatment Market Share by Country (2021-2026) Table 121. North America Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Acinetobacter Infections Treatment Market Share Forecast by Country (2027-2032) Table 123. Europe Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Acinetobacter Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Acinetobacter Infections Treatment Market Share by Country (2021-2026) Table 126. Europe Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Acinetobacter Infections Treatment Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Acinetobacter Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Acinetobacter Infections Treatment Market Share by Country (2021-2026) Table 131. Asia-Pacific Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Acinetobacter Infections Treatment Market Share Forecast by Country (2027-2032) Table 133. Latin America Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Acinetobacter Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Acinetobacter Infections Treatment Market Share by Country (2021-2026) Table 136. Latin America Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Acinetobacter Infections Treatment Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Acinetobacter Infections Treatment Market Share by Country (2021-2026) Table 141. Middle East & Africa Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Acinetobacter Infections Treatment Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Acinetobacter Infections Treatment Product Image Figure 3. Global Acinetobacter Infections Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Acinetobacter Infections Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Acinetobacter Infections Treatment Market Share by Region (2021-2032) Figure 7. North America Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Sulbactam Image Figure 13. Global Sulbactam Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Carbapenems Image Figure 15. Global Carbapenems Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Aminoglycosides Image Figure 17. Global Aminoglycosides Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Polymyxins Image Figure 19. Global Polymyxins Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Tetracyclines Image Figure 21. Global Tetracyclines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Acinetobacter Infections Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Acinetobacter Infections Treatment Market Share by Type 2025 VS 2032 Figure 26. North America Acinetobacter Infections Treatment Market Size Share by Type (2021-2032) Figure 27. Europe Acinetobacter Infections Treatment Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Acinetobacter Infections Treatment Market Size Share by Type (2021-2032) Figure 29. Latin America Acinetobacter Infections Treatment Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Acinetobacter Infections Treatment Market Size Share by Type (2021-2032) Figure 31. ETX2514 Image Figure 32. Global ETX2514 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Nacubactam RG6080 Image Figure 34. Global Nacubactam RG6080 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Arenicin Image Figure 36. Global Arenicin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. VXD-001 Image Figure 38. Global VXD-001 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Small Molecule Antibiotic Image Figure 40. Global Small Molecule Antibiotic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. AR-401 mAB Image Figure 42. Global AR-401 mAB Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. LCB01-0371 (PO) Image Figure 44. Global LCB01-0371 (PO) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. GN-4474 Image Figure 46. Global GN-4474 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Antibacterial Antibody Image Figure 48. Global Antibacterial Antibody Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Others Image Figure 50. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Global Acinetobacter Infections Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 52. Global Acinetobacter Infections Treatment Market Share by Application 2025 VS 2032 Figure 53. North America Acinetobacter Infections Treatment Market Size Share by Application (2021-2032) Figure 54. Europe Acinetobacter Infections Treatment Market Size Share by Application (2021-2032) Figure 55. Asia-Pacific Acinetobacter Infections Treatment Market Size Share by Application (2021-2032) Figure 56. Latin America Acinetobacter Infections Treatment Market Size Share by Application (2021-2032) Figure 57. Middle East and Africa Acinetobacter Infections Treatment Market Size Share by Application (2021-2032) Figure 58. Global Top 5 and 10 Acinetobacter Infections Treatment Players Market Share by Revenue in 2025 Figure 59. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 60. North America Acinetobacter Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. North America Acinetobacter Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. North America Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 63. Europe Acinetobacter Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Europe Acinetobacter Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 66. Asia-Pacific Acinetobacter Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 67. Asia-Pacific Acinetobacter Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 69. Latin America Acinetobacter Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Acinetobacter Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Latin America Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 72. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 73. Middle East & Africa Acinetobacter Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 74. Middle East & Africa Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Sulbactam
  • Carbapenems
  • Aminoglycosides
  • Polymyxins
  • Tetracyclines
  • Others
Applications
  • ETX2514
  • Nacubactam RG6080
  • Arenicin
  • VXD-001
  • Small Molecule Antibiotic
  • AR-401 mAB
  • LCB01-0371 (PO)
  • GN-4474
  • Antibacterial Antibody
  • Others
Companies covered
  • Entasis Therapeutics
  • Roche
  • Adenium Biotech
  • Vaxdyn
  • Hsiri Therapeutics
  • Aridis Pharmaceuticals
  • LegoChem Biosciences
  • Atterx Biotherapeutics
  • Achaogen
  • Peptilogics
  • Sealife PHARMA
  • Shionogi
  • Techulon
  • Tetraphase Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Acinetobacter Infections Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Acinetobacter Infections Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Acinetobacter Infections Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Acinetobacter Infections Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Acinetobacter Infections Treatment Market Size (2021-2032)
  8. 1.5.1 North America Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Acinetobacter Infections Treatment Market Size Growth Rate (2021-2032)
2 Acinetobacter Infections Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Sulbactam
  3. 2.1.2 Carbapenems
  4. 2.1.3 Aminoglycosides
  5. 2.1.4 Polymyxins
  6. 2.1.5 Tetracyclines
  7. 2.1.6 Others
  8. 2.2 Global Acinetobacter Infections Treatment Market Size by Type
  9. 2.2.1 Global Acinetobacter Infections Treatment Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Acinetobacter Infections Treatment Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Acinetobacter Infections Treatment Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Acinetobacter Infections Treatment Market Size by Regions
  13. 2.3.1 North America Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Acinetobacter Infections Treatment Market Size Breakdown by Type (2021-2026)
3 Acinetobacter Infections Treatment Market by Pipeline
  1. 3.1 Type Introduction
  2. 3.1.1 ETX2514
  3. 3.1.2 Nacubactam RG6080
  4. 3.1.3 Arenicin
  5. 3.1.4 VXD-001
  6. 3.1.5 Small Molecule Antibiotic
  7. 3.1.6 AR-401 mAB
  8. 3.1.7 LCB01-0371 (PO)
  9. 3.1.8 GN-4474
  10. 3.1.9 Antibacterial Antibody
  11. 3.1.10 Others
  12. 3.2 Global Acinetobacter Infections Treatment Market Size by Pipeline
  13. 3.2.1 Global Acinetobacter Infections Treatment Market Size Overview by Pipeline (2021-2032)
  14. 3.2.2 Global Acinetobacter Infections Treatment Historic Market Size Review by Pipeline (2021-2026)
  15. 3.2.3 Global Acinetobacter Infections Treatment Market Size Forecasted by Pipeline (2027-2032)
  16. 3.3 Global Acinetobacter Infections Treatment Market Size by Regions
  17. 3.3.1 North America Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026)
  18. 3.3.2 Europe Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026)
  19. 3.3.3 Asia-Pacific Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026)
  20. 3.3.4 South America Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026)
  21. 3.3.5 Middle East and Africa Acinetobacter Infections Treatment Market Size Breakdown by Pipeline (2021-2026)
4 Global Market Dynamics
  1. 4.1 Acinetobacter Infections Treatment Industry Trends
  2. 4.2 Acinetobacter Infections Treatment Industry Drivers
  3. 4.3 Acinetobacter Infections Treatment Industry Opportunities and Challenges
  4. 4.4 Acinetobacter Infections Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Acinetobacter Infections Treatment Revenue (2021-2026)
  2. 5.2 Global Acinetobacter Infections Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Acinetobacter Infections Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Acinetobacter Infections Treatment Company, Product Type & Application
  5. 5.5 Global Acinetobacter Infections Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Acinetobacter Infections Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Acinetobacter Infections Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Acinetobacter Infections Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Entasis Therapeutics
  2. 6.1.1 Entasis Therapeutics Company Information
  3. 6.1.2 Entasis Therapeutics Business Overview
  4. 6.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Product Portfolio
  6. 6.1.5 Entasis Therapeutics Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Roche Acinetobacter Infections Treatment Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Adenium Biotech
  14. 6.3.1 Adenium Biotech Company Information
  15. 6.3.2 Adenium Biotech Business Overview
  16. 6.3.3 Adenium Biotech Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Adenium Biotech Acinetobacter Infections Treatment Product Portfolio
  18. 6.3.5 Adenium Biotech Recent Developments
  19. 6.4 Vaxdyn
  20. 6.4.1 Vaxdyn Company Information
  21. 6.4.2 Vaxdyn Business Overview
  22. 6.4.3 Vaxdyn Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Vaxdyn Acinetobacter Infections Treatment Product Portfolio
  24. 6.4.5 Vaxdyn Recent Developments
  25. 6.5 Hsiri Therapeutics
  26. 6.5.1 Hsiri Therapeutics Company Information
  27. 6.5.2 Hsiri Therapeutics Business Overview
  28. 6.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Product Portfolio
  30. 6.5.5 Hsiri Therapeutics Recent Developments
  31. 6.6 Aridis Pharmaceuticals
  32. 6.6.1 Aridis Pharmaceuticals Company Information
  33. 6.6.2 Aridis Pharmaceuticals Business Overview
  34. 6.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Portfolio
  36. 6.6.5 Aridis Pharmaceuticals Recent Developments
  37. 6.7 LegoChem Biosciences
  38. 6.7.1 LegoChem Biosciences Company Information
  39. 6.7.2 LegoChem Biosciences Business Overview
  40. 6.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Product Portfolio
  42. 6.7.5 LegoChem Biosciences Recent Developments
  43. 6.8 Atterx Biotherapeutics
  44. 6.8.1 Atterx Biotherapeutics Company Information
  45. 6.8.2 Atterx Biotherapeutics Business Overview
  46. 6.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Product Portfolio
  48. 6.8.5 Atterx Biotherapeutics Recent Developments
  49. 6.9 Achaogen
  50. 6.9.1 Achaogen Company Information
  51. 6.9.2 Achaogen Business Overview
  52. 6.9.3 Achaogen Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Achaogen Acinetobacter Infections Treatment Product Portfolio
  54. 6.9.5 Achaogen Recent Developments
  55. 6.10 Peptilogics
  56. 6.10.1 Peptilogics Company Information
  57. 6.10.2 Peptilogics Business Overview
  58. 6.10.3 Peptilogics Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Peptilogics Acinetobacter Infections Treatment Product Portfolio
  60. 6.10.5 Peptilogics Recent Developments
  61. 6.11 Sealife PHARMA
  62. 6.11.1 Sealife PHARMA Company Information
  63. 6.11.2 Sealife PHARMA Business Overview
  64. 6.11.3 Sealife PHARMA Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sealife PHARMA Acinetobacter Infections Treatment Product Portfolio
  66. 6.11.5 Sealife PHARMA Recent Developments
  67. 6.12 Shionogi
  68. 6.12.1 Shionogi Company Information
  69. 6.12.2 Shionogi Business Overview
  70. 6.12.3 Shionogi Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Shionogi Acinetobacter Infections Treatment Product Portfolio
  72. 6.12.5 Shionogi Recent Developments
  73. 6.13 Techulon
  74. 6.13.1 Techulon Company Information
  75. 6.13.2 Techulon Business Overview
  76. 6.13.3 Techulon Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Techulon Acinetobacter Infections Treatment Product Portfolio
  78. 6.13.5 Techulon Recent Developments
  79. 6.14 Tetraphase Pharmaceuticals
  80. 6.14.1 Tetraphase Pharmaceuticals Company Information
  81. 6.14.2 Tetraphase Pharmaceuticals Business Overview
  82. 6.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Portfolio
  84. 6.14.5 Tetraphase Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Acinetobacter Infections Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst